Commonly used drugs for lung cancer are mostly seen in chemotherapy, gene targeted therapy, and immunotherapy related drugs.
Targeted agents: ALK rearrangement positive:crizotinib, erlotinib, ceritinib, aletinib, brugitinib, loratinib; EGFR erlotinib, gefitinib, erlotinib hydrochloride, afatinib, ositinib; BRAF V600E dabrafenib trametinib; MET gene amplification or MET gene exon 14 jump mutation can use crizotinib; RET rearrangement cabozantinib, vandetanib (Vandetanib); HER2 mutation T-DM1.
Chemotherapeutics: Kenzyme + platinum paclitaxel + platinum; isoproterenol + platinum; CPT-11 + platinum; etoposide + platinum
Immunologic drugs: K drugs, O drugs, etc.